Tejara Capital’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-499,106
Closed -$104K 74
2024
Q3
$104K Sell
499,106
-1,288
-0.3% -$412 0.05% 53
2024
Q2
$116K Hold
500,394
0.04% 66
2024
Q1
$430K Buy
500,394
+100,000
+25% +$68.5K 0.16% 66
2023
Q4
$156K Hold
400,394
0.07% 64
2023
Q3
$641K Sell
400,394
-41,411
-9% -$114K 0.36% 48
2023
Q2
$1.29M Buy
441,805
+18,663
+4% +$42.3K 0.64% 39
2023
Q1
$1.02M Buy
423,142
+18,467
+5% +$51.2K 0.52% 45
2022
Q4
$757K Buy
+404,675
New +$632K 0.44% 52

Other funds holding RNLX

Tejara Capital's RNLX Position: Q4 2024 in Review

Tejara Capital sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 499,106 shares — an estimated $104K sold.

Tejara Capital first reported a position in RNLX in Q4 2022 and held it in 8 quarters. The position peaked at $1.29M in Q2 2023. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

  • Tejara Capital reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Tejara Capital sold 499,106 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $104K.
  • Tejara Capital first reported a position in Renalytix plc American Depositary Shares in Q4 2022 and held it in 8 quarters.
  • Tejara Capital's Renalytix plc American Depositary Shares position peaked at $1.29M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on Tejara Capital's 13F filing for Q4 2024, filed 10 Feb 2025.